Cargando…

Identification of novel hyper- or hypomethylated CpG sites and genes associated with atherosclerotic plaque using an epigenome-wide association study

DNA methylation is an important epigenetic modification that has been implicated in the pathogenesis of atherosclerosis. Although previous studies have identified various CpG sites and genes whose methylation is associated with atherosclerosis in populations with European or Mexican ancestry, the ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Yoshiji, Horibe, Hideki, Oguri, Mitsutoshi, Sakuma, Jun, Takeuchi, Ichiro, Yasukochi, Yoshiki, Kato, Kimihiko, Sawabe, Motoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846673/
https://www.ncbi.nlm.nih.gov/pubmed/29436575
http://dx.doi.org/10.3892/ijmm.2018.3453
_version_ 1783305609745006592
author Yamada, Yoshiji
Horibe, Hideki
Oguri, Mitsutoshi
Sakuma, Jun
Takeuchi, Ichiro
Yasukochi, Yoshiki
Kato, Kimihiko
Sawabe, Motoji
author_facet Yamada, Yoshiji
Horibe, Hideki
Oguri, Mitsutoshi
Sakuma, Jun
Takeuchi, Ichiro
Yasukochi, Yoshiki
Kato, Kimihiko
Sawabe, Motoji
author_sort Yamada, Yoshiji
collection PubMed
description DNA methylation is an important epigenetic modification that has been implicated in the pathogenesis of atherosclerosis. Although previous studies have identified various CpG sites and genes whose methylation is associated with atherosclerosis in populations with European or Mexican ancestry, the genome-wide pattern of DNA methylation in the atherosclerotic human aorta is yet to be elucidated in Japanese individuals. In the present study, a genome-wide analysis of DNA methylation at ~853,000 CpG sites was performed using 128 postmortem aortic intima specimens obtained from 64 Japanese patients. To avoid the effects of interindividual variation, intraindividual paired comparisons were performed between atheromatous plaque lesions and corresponding plaque-free tissue for each patient. Bisulfite-modified genomic DNA was analyzed using a specific microarray for DNA methylation. DNA methylation at each CpG site was calculated as the β value, where β = (intensity of the methylated allele)/(intensity of the methylated allele + intensity of the unmethylated allele + 100). Bonferroni's correction for statistical significance of association was applied to compensate for multiple comparisons. The methylation of 2,679 CpG sites differed significantly (P<5.86×10(−8)) between atheromatous plaque lesions and the corresponding plaque-free intima, with 2,272 and 407 CpG sites in atheromatous plaques being hyper- or hypomethylated, respectively. A total of 5 hypermethylated CpG sites in atheromatous plaques were demonstrated to have a difference in β value of >0.15 (plaque lesion-plaque-free intima) and 11 had a β ratio of >1.50 (plaque/plaque-free intima). A further 15 and 17 hypomethylated CpG sites in atheromatous plaques were observed to have a difference in β value of <−0.15 or a β ratio of <0.67, respectively. According to these limits, a total of 16 novel genes that were significantly hyper- or hypomethylated in atheromatous plaque lesions compared with the plaque-free intima were identified in the present study. The results of the present study suggest that the methylation of these genes may contribute to the pathogenesis of atherosclerosis in the Japanese population.
format Online
Article
Text
id pubmed-5846673
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-58466732018-03-20 Identification of novel hyper- or hypomethylated CpG sites and genes associated with atherosclerotic plaque using an epigenome-wide association study Yamada, Yoshiji Horibe, Hideki Oguri, Mitsutoshi Sakuma, Jun Takeuchi, Ichiro Yasukochi, Yoshiki Kato, Kimihiko Sawabe, Motoji Int J Mol Med Articles DNA methylation is an important epigenetic modification that has been implicated in the pathogenesis of atherosclerosis. Although previous studies have identified various CpG sites and genes whose methylation is associated with atherosclerosis in populations with European or Mexican ancestry, the genome-wide pattern of DNA methylation in the atherosclerotic human aorta is yet to be elucidated in Japanese individuals. In the present study, a genome-wide analysis of DNA methylation at ~853,000 CpG sites was performed using 128 postmortem aortic intima specimens obtained from 64 Japanese patients. To avoid the effects of interindividual variation, intraindividual paired comparisons were performed between atheromatous plaque lesions and corresponding plaque-free tissue for each patient. Bisulfite-modified genomic DNA was analyzed using a specific microarray for DNA methylation. DNA methylation at each CpG site was calculated as the β value, where β = (intensity of the methylated allele)/(intensity of the methylated allele + intensity of the unmethylated allele + 100). Bonferroni's correction for statistical significance of association was applied to compensate for multiple comparisons. The methylation of 2,679 CpG sites differed significantly (P<5.86×10(−8)) between atheromatous plaque lesions and the corresponding plaque-free intima, with 2,272 and 407 CpG sites in atheromatous plaques being hyper- or hypomethylated, respectively. A total of 5 hypermethylated CpG sites in atheromatous plaques were demonstrated to have a difference in β value of >0.15 (plaque lesion-plaque-free intima) and 11 had a β ratio of >1.50 (plaque/plaque-free intima). A further 15 and 17 hypomethylated CpG sites in atheromatous plaques were observed to have a difference in β value of <−0.15 or a β ratio of <0.67, respectively. According to these limits, a total of 16 novel genes that were significantly hyper- or hypomethylated in atheromatous plaque lesions compared with the plaque-free intima were identified in the present study. The results of the present study suggest that the methylation of these genes may contribute to the pathogenesis of atherosclerosis in the Japanese population. D.A. Spandidos 2018-05 2018-02-02 /pmc/articles/PMC5846673/ /pubmed/29436575 http://dx.doi.org/10.3892/ijmm.2018.3453 Text en Copyright: © Yamada et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Yamada, Yoshiji
Horibe, Hideki
Oguri, Mitsutoshi
Sakuma, Jun
Takeuchi, Ichiro
Yasukochi, Yoshiki
Kato, Kimihiko
Sawabe, Motoji
Identification of novel hyper- or hypomethylated CpG sites and genes associated with atherosclerotic plaque using an epigenome-wide association study
title Identification of novel hyper- or hypomethylated CpG sites and genes associated with atherosclerotic plaque using an epigenome-wide association study
title_full Identification of novel hyper- or hypomethylated CpG sites and genes associated with atherosclerotic plaque using an epigenome-wide association study
title_fullStr Identification of novel hyper- or hypomethylated CpG sites and genes associated with atherosclerotic plaque using an epigenome-wide association study
title_full_unstemmed Identification of novel hyper- or hypomethylated CpG sites and genes associated with atherosclerotic plaque using an epigenome-wide association study
title_short Identification of novel hyper- or hypomethylated CpG sites and genes associated with atherosclerotic plaque using an epigenome-wide association study
title_sort identification of novel hyper- or hypomethylated cpg sites and genes associated with atherosclerotic plaque using an epigenome-wide association study
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846673/
https://www.ncbi.nlm.nih.gov/pubmed/29436575
http://dx.doi.org/10.3892/ijmm.2018.3453
work_keys_str_mv AT yamadayoshiji identificationofnovelhyperorhypomethylatedcpgsitesandgenesassociatedwithatheroscleroticplaqueusinganepigenomewideassociationstudy
AT horibehideki identificationofnovelhyperorhypomethylatedcpgsitesandgenesassociatedwithatheroscleroticplaqueusinganepigenomewideassociationstudy
AT ogurimitsutoshi identificationofnovelhyperorhypomethylatedcpgsitesandgenesassociatedwithatheroscleroticplaqueusinganepigenomewideassociationstudy
AT sakumajun identificationofnovelhyperorhypomethylatedcpgsitesandgenesassociatedwithatheroscleroticplaqueusinganepigenomewideassociationstudy
AT takeuchiichiro identificationofnovelhyperorhypomethylatedcpgsitesandgenesassociatedwithatheroscleroticplaqueusinganepigenomewideassociationstudy
AT yasukochiyoshiki identificationofnovelhyperorhypomethylatedcpgsitesandgenesassociatedwithatheroscleroticplaqueusinganepigenomewideassociationstudy
AT katokimihiko identificationofnovelhyperorhypomethylatedcpgsitesandgenesassociatedwithatheroscleroticplaqueusinganepigenomewideassociationstudy
AT sawabemotoji identificationofnovelhyperorhypomethylatedcpgsitesandgenesassociatedwithatheroscleroticplaqueusinganepigenomewideassociationstudy